Last updated 9 months ago

Efficacy and Safety of GSK4527226 [AL101] in Participants With Early Alzheimer's Disease

282 patients around the world
Available in Spain, Argentina, United States
GlaxoSmithKline
4Research sites
282Patients around the world

This study is for people with

Alzheimer disease

Requirements for the patient

To 85 Years
All Gender

Medical requirements

Sites

Centro de Investigaciones Metabólicas (CINME) S.A. - CABA, Buenos Aires
Centro de Investigaciones Metabólicas (CINME) S.A. - CABA, Buenos Aires
Recruiting
Viamonte, Cdad. Autónoma de Buenos Aires, Argentina
CEMIC - Hospital Universitario Sede Saavedra - CABA, Buenos Aires
CEMIC - Hospital Universitario Sede Saavedra - CABA, Buenos Aires
Recruiting
Av. Galvan 4102, CABA, Buenos Aires
Centro Médico Maffei - CABA, Buenos Aires
Centro Médico Maffei - CABA, Buenos Aires
Recruiting
Av. Cerviño 3375, CABA, Buenos Aires
Fleni - sede Belgrano
Recruiting
Montañeses 2325, CABA, Buenos Aires
LinkedinInstagramFacebook
Terms and ConditionsPrivacy Policy